CREDIT SUISSE AG/ - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$32,333,584
-30.3%
1,567,309
-0.4%
0.03%
-28.3%
Q2 2023$46,420,647
+29.7%
1,573,048
+1.3%
0.05%
+27.8%
Q1 2023$35,791,995
-16.1%
1,553,472
+1.3%
0.04%
-20.0%
Q4 2022$42,643,381
-13.8%
1,533,383
-4.8%
0.04%
-18.2%
Q3 2022$49,455,000
-14.3%
1,611,429
-17.8%
0.06%
-8.3%
Q2 2022$57,683,000
-8.5%
1,960,025
+0.1%
0.06%
+11.1%
Q1 2022$63,008,000
-28.1%
1,958,574
-0.3%
0.05%
+14.9%
Q4 2021$87,579,000
-12.4%
1,963,648
-0.9%
0.05%
-14.5%
Q3 2021$100,015,000
-35.2%
1,982,473
+0.8%
0.06%
-32.9%
Q2 2021$154,253,000
+38.0%
1,966,508
+0.4%
0.08%
+43.9%
Q1 2021$111,802,000
-4.8%
1,957,993
+39.6%
0.06%0.0%
Q4 2020$117,494,000
+3934.8%
1,402,750
+1626.2%
0.06%
+2750.0%
Q3 2020$2,912,000
+17.3%
81,264
-20.8%
0.00%0.0%
Q2 2020$2,483,000
+243.4%
102,647
+148.5%
0.00%
+100.0%
Q1 2020$723,000
-1.2%
41,307
-1.7%
0.00%0.0%
Q4 2019$732,000
-0.3%
42,004
-12.3%
0.00%0.0%
Q3 2019$734,000
-14.1%
47,898
+16.3%
0.00%0.0%
Q2 2019$854,000
-19.7%
41,187
-10.0%
0.00%0.0%
Q1 2019$1,063,000
+16.8%
45,764
+3.8%
0.00%0.0%
Q4 2018$910,000
+61.3%
44,091
+70.3%
0.00%0.0%
Q3 2018$564,000
+211.6%
25,894
+117.0%
0.00%
Q2 2018$181,00011,9340.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders